Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy

Journal of Investigative Dermatology

Volumn 117, Issue 4, 2001, Pages 858-863

  Pellet, C ^a   Chevret, S ^b   Blum, L ^b   Gauville C ^a   Hurault, M ^a   Blanchard, G ^c   Agbalika, F ^d   Lascoux, C ^b   Ponscarme, D ^b   Morel, P ^e   Calvo, F ^a   Lebbe C ^a,e  

^a Laboratory of Pharmacology   (France)

^b Department of Biostatistics ^*  (France)

^c Unité Fonctionnelle d'Hématologie Centre Hospitalier Général René Dubos   (France)

^d Unit of Virology   (France)

^e SAINT LOUIS HOSPITAL   (France)

Author keywords

Highly active antiretroviral therapy; Kaposi's sarcoma; KSHV viral load; Predictive factors

Indexed keywords

BLEOMYCIN; DAUNORUBICIN; DIDANOSINE; DOCETAXEL; INDINAVIR; LAMIVUDINE; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FOLLOW UP; GENE EXPRESSION; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MONONUCLEAR CELL; OPEN READING FRAME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; VIREMIA; VIRUS LOAD;

EID: 0034773293     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202X.2001.01465.x     Document Type: Article

References (31)

1. Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients
2. Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy
3. Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma
4. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: Biologic correlates of clinical outcome
5. Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment
6. The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma
7. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients
8. Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis
9. Infection of circulating CD34+ cells by HHV-8 in patients with Kaposi's sarcoma
10. Survival of European patients with Kaposi's sarcoma as AIDS-defining condition during the first decade of AIDS
11. HHV8 and Kaposi's sarcoma: A time cohort study
12. Kaposi's sarcoma in the acquired immune deficiency syndrome: A proposal for uniform evaluation, response, and staging criteria
13. AIDS-related Kaposi's sarcoma: Prospective validation of the AIDS Clinical Trials Group staging classification
14. Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay
15. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma
16. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: The Swiss HIV Cohort Study
17. Activity of thalidomide in AIDS-related Kaposi's sarcoma
18. Development of a quantitative competitive polymerase chain reaction for human herpesvirus 8
19. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection
20. Improved survival for patients with AIDS-related Kaposi's sarcoma
21. Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: Results from the EuroSIDA study
22. Clearance of human herpesvirus type 8 viraemia in HIV-1-positive patients with Kaposi's sarcoma treated with liposomal doxorubicin
23. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure
24. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients
25. Identification of human herpesvirus 8-specific cytotoxic T-cell responses
26. Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells
27. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma
28. Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion. Italian Seroconversion Study
29. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8)
30. Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy
31. Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus